Bio

Kristan L. Lansbery, Ph.D. is an attorney with corporate and law firm leadership experience. As a Director within the legal department at Regeneron Pharmaceuticals, she oversees a team responsible for global patent protection of downstream platform technologies, trade secret protection, and freedom to operate. In that capacity, she partners with multiple research and business functions to assist the scientists, regulatory group, and other corporate stakeholders. Examples of her work at Regeneron include developing processes for multiple scientific and business groups to designate trade secrets and partnering with litigators to prepare for product launches.

Prior to Regeneron, Dr. Lansbery was a partner at Arnold & Porter LLP, where she managed teams responsible for the worldwide prosecution of life science patent portfolios. She also was lead counsel on several contentious matters before the Patent Trial and Appeal Board, and she has successfully argued ex parte appeals and litigated disputes related to polymerase chain reaction, drug-eluting stents, therapeutic antibodies, and diagnostic nucleic acids.

Dr. Lansbery’s practice is recognized by multiple publications, including IAM Patent 1000, and she has taught Biotechnology and Patent Law at Georgetown University. She earned her Ph.D. in Molecular Cell Biology from Washington University in St. Louis, and attended law school at the George Washington University.

Sub-specialties: Intellectual Property, Patents, Trade Secrets, Life Sciences, Pharmaceuticals, Antibodies, Manufacturing of biologics

SHARE

[SHARE]

Expert DirectLink

Articles, Publications, Appearances